Showing results (751-760 of 1,142) with videos related to

Sort By:
Pageof 115
JHEP Reports : Innovation in Hepatology|August 21, 2023
Predicting overt hepatic encephalopathy after TIPS: Value of three minimal hepatic encephalopathy testsAlena F Ehrenbauer, Hannah Schneider, Lena Stockhoff, et al.
Genes, Brain, and Behavior|August 24, 2017
Heterogeneous stock rats: a model to study the genetics of despair-like behavior in adolescenceK Holl, H He, M Wedemeyer, et al.
Zeitschrift Fur Gastroenterologie|February 9, 2010
[CMV-enterocolitis as a cause for repeated intestinal intussusceptions in an adult patient after liver transplantation?]S Pischke, O Tutarel, T F Greten, et al.
Journal of Hepatology|June 25, 2017
Safety of the 2D/3D direct-acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis - A pooled analysisFred Poordad, David R Nelson, Jordan J Feld, et al.
Journal of Hepatology|February 10, 2024
Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsiesLena Allweiss, Annika Volmari, Vithika Suri, et al.
Neuro-Oncology Advances|June 30, 2022
Epigenetic dysregulation in meningiomasMichelle A Wedemeyer, Ivo Muskens, Ben A Strickland, et al.
Operative Neurosurgery (Hagerstown, Md.)|September 11, 2019
Hemorrhagic Presentation of Rathke Cleft Cysts: A Surgical Case SeriesLauren Schooner, Michelle A Wedemeyer, Phillip A Bonney, et al.
Journal of Immunological Methods|November 26, 2002
Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexesTim F Greten, Firouzeh Korangy, Gunnar Neumann, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2003
Multiple elements of the allergic arm of the immune response modulate autoimmune demyelinationRosetta Pedotti, Jason J DeVoss, Sawsan Youssef, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2018
Clinical significance of detectable and quantifiable HCV RNA at the end of treatment with ledipasvir/sofosbuvir in GT1 patientsBenjamin Maasoumy, Peter Buggisch, Stefan Mauss, et al.
Pageof 115